TWST News and Press, Twist Bioscience Corporation From 11/02/23

2023-11-02 16:55:06 ET Summary Today, we take a look synthetic biology company Twist Bioscience Corporation for the first time since spring. The company recently signed collaboration deals with two new drugmakers and saw upward analyst price target revisions after strong Q2 result...

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2023 fourth quarter and full year ended September 30, 2023, b...

Adds to robust offering of NGS tools enabling exome sequencing, whole genome sequencing, RNA sequencing and methylation detection Enables multiplexing and high throughput sequencing New offering expands and complements Twist’s portfolio of universal adapters Twist Full Length U...

2023-10-05 12:10:43 ET More on Bayer Bayer: Undervalued With Clear Catalysts Twist Bioscience: Progress Hidden By Execution Issues And Soft Demand Bayer: Still A Strong Buy Despite Lowered Guidance FMC, Bayer downgraded to Neutral at Redburn Atlantic on crop-...

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced an antibody discovery, option and license agreement with Bayer. Under the terms of the agreement, Twist Biopharma S...

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Mark Buck as senior vice president, operations. Mr. Buck brings experience improving manufacturi...

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and IMIDomics, Inc ., a patient-centric drug discovery and development company focused on Immune-Mediated Inflammatory Diseases...

2023-08-31 06:45:33 ET More on Twist Twist Bioscience: Progress Hidden By Execution Issues And Soft Demand Twist Bioscience: Evaluating Its Conglomerate Of Innovation, Growth, And Vulnerabilities Twist Bioscience Corporation ( TWST ) Q3 2023 Earnings Call Trans...

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a drug discovery agreement with Ono Pharmaceutical Co. , Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; &#x...

2023-08-29 17:26:54 ET Gainers: Vimeo ( NASDAQ: VMEO ) +6% . Twist Bioscience  ( TWST ) +5% . Iris Energy ( IREN ) +4% . Poseida Therapeutics ( PSTX ) +4% . Conn's ( CONN ) +3% . Losers: Ambarella ( AMBA ) ...